GLD Acquires Seelos Therapeutics’ Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials
Read MoreAlternative Investment with Vision.Integrity.Discipline.
We are a global alternative investment management firm that builds long-term value across private credit, private equity, and real estate.
Alternative Investment.
Done Right.
GLD is focused on generating strong risk-adjusted returns. We invest with discipline, operate with rigor, and align our interests with those of our investors and portfolio companies.
Our approach is built on market expertise, careful capital allocation, and a long-term orientation. We navigate complexity and deliver consistent performance across market cycles.
Our Investment Strategies
Private Credit
We invest across the full credit spectrum, from traditional debt to distressed and private credit, with one goal: finding value where others don't look.
Private Equity
We find businesses others overlook and help them reach their potential through smart capital, focused strategy, and active management.
Real Estate
We invest in undervalued, underleveraged real estate where capital and repositioning can unlock real returns.
Portfolio Spotlight
Advancing First-in-Class Therapies
Altagenics translates breakthrough functional genomics into innovative therapies addressing one of healthcare’s most significant unmet needs.
Leveraging Heligenics’ GigaAssay™ platform, Altagenics will accelerate the discovery of novel compounds for muscle wasting and muscle growth.
News & Perspectives
GLD Launches New Biotech Company, Altagenics, to Accelerate Drug Discovery for Muscle-Wasting Diseases
In collaboration with Heligenics GigaAssay™ platform, the companies will speed the development of new therapies in aging-related diseases.
Read More
Strategy Only Matters if It’s Executed Well
At GLD, we combine strong ideas with disciplined execution. If you’re exploring partnerships or want to learn more, we’re ready to talk.
Let's Talk
Whether you're an investor, a potential partner, or just curious - we'd love to hear from you.
By Contacting us, you agree to our Terms of Service
and Privacy Policy